LABD - Direxion Daily S&P Biotech Bear 3X ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
23.66
-0.07 (-0.29%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close23.73
Open23.62
Bid0.00 x 1000
Ask0.00 x 800
Day's Range23.29 - 23.93
52 Week Range21.35 - 603.00
Volume1,336,401
Avg. Volume1,379,204
Net Assets73.21M
NAV21.63
PE Ratio (TTM)N/A
Yield0.32%
YTD Return-52.86%
Beta (3y)-7.45
Expense Ratio (net)0.96%
Inception Date2015-05-28
Trade prices are not sourced from all markets
  • How venture philanthropy is helping to find a diabetes cure
    Yahoo Finance Video10 months ago

    How venture philanthropy is helping to find a diabetes cure

    JDRF T1D Fund is a private equity fund that pays for diabetes research. Yahoo Finance’s Alexis Christoforous talks with JDRF T1D Fund chairman Sean Doherty about the company’s projects. For more information, copy and paste this link into your browser: www.t1dfund.org Or, email: t1dfund@jdrf.org

  • GE made a mistake slashing its dividend, and the entire Dow is paying the price today: NYSE trader
    Yahoo Finance Video10 months ago

    GE made a mistake slashing its dividend, and the entire Dow is paying the price today: NYSE trader

    Alan Valdes, director of floor operations at Silverbear Capital, joins Yahoo Finance's Alexis Christoforous from the floor of the New York Stock Exchange to discuss why stocks are down today.

  • Yellen, Draghi, Carney and Kuroda met in Frankfurt today—here's what went down
    Yahoo Finance Video10 months ago

    Yellen, Draghi, Carney and Kuroda met in Frankfurt today—here's what went down

    The world's most powerful central bankers met in Frankfurt, Germany on Tuesday. Yahoo Finance's Jared Blikre weighs in on what the heads of the US Federal Reserve, European Central Bank, Bank of England and Bank of Japan had to say.

  • The biggest market-mover this week is the 'argy bargy' on taxes down in the Beltway: NYSE trader
    Yahoo Finance Video10 months ago

    The biggest market-mover this week is the 'argy bargy' on taxes down in the Beltway: NYSE trader

    Keith Bliss of Cuttone and Company joins Yahoo Finance's Alexis Christoforous from the floor of the New York Stock Exchange to discuss what's set to move stocks this week.

  • Nvidia and Intel are set to be long-term market leaders
    Yahoo Finance Video11 months ago

    Nvidia and Intel are set to be long-term market leaders

    Nvidia shares soared early Friday after reporting third quarter results that exceeded Wall Street expectations in nearly every category. Yahoo Finance's Jared Blikre explains why he thinks Nvidia and Intel are the stocks to watch going forward.

  • Stocks have bigger problems than tax reform
    Yahoo Finance Video11 months ago

    Stocks have bigger problems than tax reform

    All three major indexes started the day lower on Friday as investors continued to fret over the details of the Senate tax bill. Yahoo Finance's Jared Blikre explains that tax reform is not the only concern Wall Street has right now.

  • 3 signs the bulls are still kicking
    Yahoo Finance Video11 months ago

    3 signs the bulls are still kicking

    Stocks may be taking a breather today, but that doesn't mean the bulls have run out of steam. Yahoo Finance's Justine Underhill had more.

  • Why the Broadcom bid for Qualcomm may end in a proxy battle
    Yahoo Finance Video11 months ago

    Why the Broadcom bid for Qualcomm may end in a proxy battle

    Broadcom made an unsolicited bid for Qualcomm early Monday. The $70 a share offer values the deal at a whopping $130 billion. Yahoo Finance's Alexis Christoforous and Jared Blikre discuss what are the odds this deal will get regulatory approval, and what it could mean for the chip industry.

  • How the Biotech Sector Has Fared this Year
    Market Realist26 days ago

    How the Biotech Sector Has Fared this Year

    Usually, when investors add biotechnology stocks to their portfolios, they feel confident about risk. When they want to reduce risk, biotech names are the first to go. LABU (3X Biotech Bull) and LABD (3X Biotech Bear) can help you stay risk-on or risk-off.

  • Benzinga2 months ago

    Exploring The Leveraged ETF Trade Heading Into Earnings Season

    Many institutional traders use multi-faceted strategies that involve several different instruments when trading around an earnings report. Among the most common hedging tools used by institutions are leveraged ETFs, which are built to deliver multiples (or inverse multiples) on a given index. “They aren’t meant to be held for more than a few days at a time,” Sylvia Jablonski, managing director of leveraged ETF provider Direxion ETFs said.

  • Benzinga6 months ago

    For Now, Traders Endorse Biotech Rally

    Among leveraged and inverse biotechnology exchange-traded funds, the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU ) and the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD ) are the dominant ...

  • Direxion Announces Reverse Splits of Five ETFs
    PR Newswire7 months ago

    Direxion Announces Reverse Splits of Five ETFs

    NEW YORK , Feb. 28, 2018 /PRNewswire/ -- Direxion has announced it will execute a reverse split of the issued and outstanding shares of the Direxion Daily Technology Bear 3X Shares, Direxion Daily Energy ...

  • Benzinga10 months ago

    Short Interest And Leveraged ETFs

    Short interest is a popular metric on Wall Street because it gives a peek into the amount of negative sentiment a stock has. For their part, leveraged ETFs thrive on the directionality short interest can ...

  • Benzinga10 months ago

    Latest Tax Reform Bill From Senate GOP Seeks Repeal Of ACA Individual Mandate

    The latest Republican tax reform bill takes yet another stab at the Affordable Care Act with a proposed repeal of individual mandates, party leadership said Tuesday . The mandates had required Americans ...